CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility

Neutral
AI Analysis

Summary

Inhibikase Therapeutics announced the sale of $50 million in shares through its at-the-market (ATM) facility to raise capital.

Importance:5/10
Sentiment:
0.20
capital_raiseATM_facilityequity_offering
Related Companies

Read the original article

Published by yahoo_finance on July 14, 2026 12:00 PM

Read Original